Periodic benefit‐risk evaluation reports have substantial promise to guide patient care and should be made publicly available
Michael Fralick; Aaron S. Kesselheim
Author Information: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.